Molecular aspects of fluconazole resistance development in Candida albicans

Mycoses

Volumn 42, Issue 7-8, 1999, Pages 453-458

  Franz, Renate ^a   Ruhnke, M ^b   Morschhäuser, Joachim ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Candida albicans; DNA fingerprinting; Epidemiology; Fluconazole; Resistance

Indexed keywords

ABC TRANSPORTER; CARRIER PROTEIN; FLUCONAZOLE; GENE PRODUCT; MESSENGER RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; GENE EXPRESSION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PHARYNGITIS; PRIORITY JOURNAL; RECURRENT INFECTION; THRUSH;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; DRUG RESISTANCE, MICROBIAL; FLUCONAZOLE; HUMANS;

CANDIDA ALBICANS;

EID: 0032888237     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.1999.00498.x     Document Type: Article

References (18)

1. 1 Rex, J. H., Rinaldi, M. G. & Pfaller, M. A. (1995) Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39, 1-8.
2. 2 Vanden Bossche, H., Marichal, P. & Odds, F. C. (1994) Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2, 393-400.
3. 3 Albertson, G. D., Niimi, M., Cannon, R. D. & Jenkinson, H. F. (1996) Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob. Agents Chemother. 40, 2835-2841.
4. 4 Franz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M. & Morschhäuser, J. (1998) Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42, 3065-3072.
5. 5 Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M. & Bille, J. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39, 2378-2386.
6. 6 Sanglard, D., Ischer, F., Monod, M. & Bille, J. (1997) Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143, 405-416.
7. 7 White, T. C. (1997) Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 41, 1482-1487.
8. 8 Ruhnke, M., Eigler, A., Tennagen, I., Geiseler, B., Engelmann, E. & Trautmann, M. (1994) Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J. Clin. Microbiol. 32, 2092-2098.
9. 9 Lischewski, A., Harmsen, D., Hacker, J. & Morschhäuser, J. (1997) Standardized molecular typing of Candida albicans strains. Mycoses 40, 369-372.
10. 10 Lockhart, S. R., Reed, B. D., Pierson, C. L. & Soll, D. R. (1996) Most frequent scenario for recurrent Candida vaginitis is strain maintenance with 'substrain shuffling': Demonstration by sequential DNA fingerprinting with probes Ca3, Cl, and CARE2. J. Clin. Microbiol. 34, 767-777.
11. 11 Schröppel, K., Rotman, M., Galask, R. & Soll, D. R. (1994) Evolution and replacement of Candida albicans strains during recurrent vaginitis demonstrated by DNA fingerprinting. J. Clin. Microbiol. 32, 2646-2654.
12. 12 White, T. C., Marr, K. A. & Bowden, R. A. (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11, 382-402.
13. 13 Bart-Delabesse, E., Boiron, P., Carlotti, A. & Dupont, B. (1993) Candida albicans genotyping in studies with patients with AIDS developing resistance to fluconazole. J. Clin. Microbiol. 31, 2933-2937.
14. 14 McCullough, M. & Hume, S. (1995) A longitudinal study of the change in resistance patterns and genetic relationship of oral Candida albicans from HIV-infected patients. J. Med. Vet. Mycol. 33, 33-37.
15. 15 Pfaller, M. A., Rhine, C. J., Redding, S. W., et al. (1994) Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J. Clin. Microbiol. 32, 59-64.
16. 16 Sanglard, D., Ischer, F., Koymans, L. & Bille, J. (1998) Amino acid substitutions in the cytochrome P-450 lanosterol 14-α-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob. Agents. Chemother. 42, 241-253.
17. 17 White, T. C. (1997) The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14-α-demethylase in Candida albicans. Antimicrob. Agents Chemother. 41, 1488-1494.
18. 5,6-desaturation. FEBS Lett. 400, 80-82.